Gilead Accelerates Immunology Strategy Through Ouro Medicines Acquisition
Gilead Sciences, Inc. (“Gilead”), a global biopharmaceutical company, has entered into a definitive agreement to acquire Ouro Medicines (“Ouro”), a privately held, clinical-stage…